Innovating Works

PERC

Desconocido
Showing 1 to 20 of 44 results
AEGEUS: AEGEUS - A Novel EEG Ultrasound Device for Functional Brain Imaging and Neurostimulation PERCUROS BV participó en un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 The overall goal of this project is to develop a radically new diagnostic and therapeutic device for neurological applications which combine...
2022-12-13 - 2027-02-28 | Financiado
BRAINSTORM: Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterials PERCUROS BV participó en un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 BRAINSTORM will introduce an innovative, scalable, wireless, multimodal nanoinvasive neuromodulation technology suitable for independent and...
2022-12-08 - 2027-03-31 | Financiado
CROSSBRAIN: Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic l... PERCUROS BV participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 A vast number of pathological brain conditions directly involve aberrant electrical activity of the brain. CROSSBRAIN centres its technologi...
2022-07-08 - 2026-10-31 | Financiado
GELNANODEP: A gel network depot for bringing advance strategies for skin cancer PERCUROS BV tramitó un H2020: H2020-MSCA-IF-2020 GELNANODEP aims at inserting in the background of the advance drug delivery systems an innovative clinical treatment for skin cancer disease...
2021-04-13 - 2023-08-31 | Financiado
PIANO: Nanoparticle Based Imaging and Therapy of Chronic Pain in the Dorsal Root Ganglia DRG PERCUROS BV participó en un H2020: H2020-MSCA-ITN-2020 Chronic pain is a debilitating disease, which affects approximately 1.5 billion people worldwide, and of those, approximately 4% suffer from...
2020-11-09 - 2025-02-28 | Financiado
CARTHAGO: Cartilaginous tissue regeneration by non viral gene therapy taking the hurdles towards efficient de... PERCUROS BV participó en un H2020: H2020-MSCA-ITN-2020 Chronic low back pain due to intervertebral disc (IVD) degeneration and osteoarthritis (OA) worldwide impact human health and well-being due...
2020-09-02 - 2024-08-31 | Financiado
Biosafety: Biosafety assays for the diagnosis and prediction of drug related complement pathology PERCUROS BV participó en un H2020: H2020-WIDESPREAD-2018-2020 The objective of this Twinning project is to significantly strengthen the research in SEMMELWEIS EGYETEM in the smart specialization area of...
2020-07-06 - 2023-08-31 | Financiado
BARRICADE: evolutionary platform to predict breast cancer BC patients outcome and response to therapy PERCUROS BV tramitó un H2020: H2020-MSCA-IF-2019 BARRICADE is about an evolutionary platform to predict breast cancer (BC) patients outcome and response to therapy in a faster and specific...
2020-05-11 - 2022-08-31 | Financiado
Gl.EXO: Innovative tools to detect Glioblastoma GBM exosomes PERCUROS BV tramitó un H2020: H2020-MSCA-IF-2019 Gl.EXO is about innovative tools to detect Glioblastoma (GBM) exosomes and to have a timely, accurate and non-invasive diagnosis of GBM. Sev...
2020-04-03 - 2022-06-30 | Financiado
BESG: Bioengineered exosomes based approaches for the effective treatment of non small cell lung cancer PERCUROS BV tramitó un H2020: H2020-MSCA-IF-2019 ABSTRACT: Lung cancer is the principal cause of cancer-related death around the world and has become more predominant among former than curr...
2020-03-04 - 2022-09-30 | Financiado
cONCReTE: DevelOpmeNt of Cancer RNA TherapEutics PERCUROS BV participó en un H2020: H2020-MSCA-RISE-2019 Non-codingRNAs (ncRNAs) represent a large class of molecules that in concert regulate the expression of genes involved in the key pathways g...
2020-03-02 - 2025-10-31 | Financiado
PRISAR2: proactive monitoring of cancer as an alternative to surgery PERCUROS BV tramitó un H2020: H2020-MSCA-RISE-2019 From 2016 -2019, the first PRISAR consortium implemented the first Dutch RISE project of H2020 to investigate the use of imaging technologie...
2019-12-02 - 2025-03-31 | Financiado
SENATOR: Staff Exchange for Novel applications in 19f magnetic resonance imaging PERCUROS BV participó en un H2020: H2020-MSCA-RISE-2019 Magnetic resonance imaging (MRI) is a leading clinical diagnostic technique, which is able to provide whole body imaging, and when individua...
2019-10-21 - 2024-04-30 | Financiado
PAVE: A nanovaccine Approach for the treatment of Pancreatic Cancer PERCUROS BV participó en un H2020: H2020-MSCA-ITN-2019 A Nanovaccine Approach For The Treatment of Pancreatic Cancer By Multicomponent Immuno-Modulation: Pancreatic ductal adenocarcinoma (PDAC) i...
2019-09-12 - 2024-03-31 | Financiado
CAST: Active Monitoring of Cancer As An Alternative To Surgery PERCUROS BV participó en un H2020: H2020-MSCA-ITN-2019 When a patient is discovered to have cancer, one of the primary goals is to have the tumour removed by surgery. Although this provides excel...
2019-09-11 - 2024-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.